Synergistic chromatin repression of the tumor suppressor gene RARB in human prostate cancers

32Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

DNA methylation and polycomb proteins are well-known mediators of epigenetic silencing in mammalian cells. Usually described as mutually exclusive, this statement is today controversial and recent in vitro studies suggest the coexistence of both repressor systems. We addressed this issue in the study of Retinoic Acid Receptor β (RARβ), a tumor suppressor gene frequently silenced in prostate cancer. We found that the RARβ promoter is hypermethylated in all studied prostate tumors and methylation levels are positively correlated with H3K27me3 enrichments. Thus, by using bisulfite conversion and pyrosequencing of immunoprecipitated H3K27me3 chromatin, we demonstrated that DNA methylation and polycomb repression co-exist in vivo at this locus. We found this repressive association in 6/6 patient tumor samples of different Gleason score, suggesting a strong interplay of DNA methylation and EZH2 to silence RARβ during prostate tumorigenesis. © 2014 Landes Bioscience.

Cite

CITATION STYLE

APA

Moison, C., Assemat, F., Daunay, A., Tost, J., Guieysse-Peugeot, A. L., & Arimondo, P. B. (2014). Synergistic chromatin repression of the tumor suppressor gene RARB in human prostate cancers. Epigenetics, 9(4), 477–482. https://doi.org/10.4161/epi.27869

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free